Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hodgkin´s Lymphoma”

50 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 50 results

Testing effectiveness (Phase 2)WithdrawnNCT01138579
What this trial is testing

Study of the Trifunctional Antibody FBTA05 and Donor Lymphocyte Infusion in B-cell Lymphoma After Allogeneic Stem Cell Transplantation

Who this might be right for
LeukemiaStem Cell Transplantation
Technical University of Munich
Not applicableLooking for participantsNCT07059741
What this trial is testing

Integrated Radiotherapy-optimized ASCT Sequential CAR-T Therapy for Patients With Relapsed and Refractory B-NHL

Who this might be right for
Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL)
The First Affiliated Hospital of Soochow University 20
Not applicableLooking for participantsNCT04968288
What this trial is testing

Natural History of KSHV-Associated Multicentric Castleman s Disease

Who this might be right for
Multicentric Castleman s Disease
National Cancer Institute (NCI) 195
Testing effectiveness (Phase 2)Study completedNCT01685008
What this trial is testing

Study of Fc-Optimized Anti-CD19 Antibody (MOR00208) to Treat Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Non-Hodgkin Lymphoma
MorphoSys AG 92
Not applicableStudy completedNCT01870479
What this trial is testing

Music & Cancer - Live Music During Chemotherapy

Who this might be right for
Non Hodgkin´s LymphomasHodgkin´s Lymphomas
Margrethe Langer Bro 143
Large-scale testing (Phase 3)Study completedNCT00265031
What this trial is testing

HD12 for Advanced Stages

Who this might be right for
Hodgkin´s Lymphoma
University of Cologne
Post-approval studies (Phase 4)Study completedNCT04349306
What this trial is testing

Evaluate the Efficacy and Safety of Rasburicase (Fasturtec®) in the Prevention and Treatment of Hyperuricemia in Pediatric Patients With Non-Hodgkin's Lymphoma and Acute Leukemia

Who this might be right for
Lymphoma
Sanofi 50
Large-scale testing (Phase 3)Looking for participantsNCT06784752
What this trial is testing

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

Who this might be right for
Somatostatin Receptor Positive (SSTR+)Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
Novartis Pharmaceuticals 240
Not applicableUnknownNCT01151358
What this trial is testing

Evaluation of Patient and Lesion Specific Prognostic Factors for Standard Radioimmunotherapy

Who this might be right for
Follicular Lymphoma
University Hospital, Saarland 150
Early research (Phase 1)Active Not RecruitingNCT02879695
What this trial is testing

Blinatumomab and Nivolumab With or Without Ipilimumab in Treating Patients With Poor-Risk Relapsed or Refractory CD19+ Precursor B-Lymphoblastic Leukemia

Who this might be right for
Recurrent B Acute Lymphoblastic LeukemiaRecurrent Mixed Phenotype Acute LeukemiaRefractory B Acute Lymphoblastic Leukemia+1 more
National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)Study completedNCT00284271
What this trial is testing

Feasibility and Efficacy of BACOPP-21 for Patients > 60 Years With Intermediate or Advanced Hodgkins Lymphoma

Who this might be right for
Hodgkin´s Lymphoma
University of Cologne 65
Post-approval studies (Phase 4)UnknownNCT05490953
What this trial is testing

Enhancing Effect on Tumour Apoptosis With the Use of Pentoxifylline in Patients With Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
University of Guadalajara 30
Not applicableActive Not RecruitingNCT06817122
What this trial is testing

The "Let's Talk Tech" Tool to Support Decision Making About Technology Use

Who this might be right for
Dementia, MildMild Cognitive Impairment (MCI)
University of Washington 240
Large-scale testing (Phase 3)Looking for participantsNCT07202078
What this trial is testing

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Starting Immunoglobulin (Start Ig)

Who this might be right for
MyelomaNon Hodgkin's LymphomaLeukemia
Monash University 900
Not applicableStudy completedNCT07653386
What this trial is testing

Clinical Trial of an Ointment in Patients With Mild and Moderate Atopic Dermatitis

Who this might be right for
Mild and Moderate Atopic Dermatitis PatientsAtopic Dermatitis (AD)
VinUniversity 90
Testing effectiveness (Phase 2)Looking for participantsNCT06066203
What this trial is testing

GNC-035 in Relapsed or Refractory Non-Hodgkin 's Lymphoma and Other Hematological Malignancies

Who this might be right for
Non-hodgkin's Lymphoma
Sichuan Baili Pharmaceutical Co., Ltd. 40
Testing effectiveness (Phase 2)Looking for participantsNCT07123454
What this trial is testing

A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
B-cell Non-Hodgkin Lymphoma
AstraZeneca 91
Not applicableLooking for participantsNCT07147621
What this trial is testing

Evaluation of Chemotherapy-induced Cognitive Disorders During the Treatment of Hematological Malignancies

Who this might be right for
Acute Myeloid LeukemiaHodgkin's LymphomaNon-Hodgkin's Lymphoma
University Hospital, Angers 120
Testing effectiveness (Phase 2)Looking for participantsNCT06090864
What this trial is testing

ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells

Who this might be right for
Hodgkin LymphomaRelapseRefractory
UNC Lineberger Comprehensive Cancer Center 31
Testing effectiveness (Phase 2)Study completedNCT01476410
What this trial is testing

Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma

Who this might be right for
Adult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin LymphomaAdult Mixed Cellularity Hodgkin Lymphoma+4 more
Northwestern University 49
Next Page